The peptide synthesis market is projected to secure a valuation of US$ 520.0 million in 2023 and is rising to US$ 1.1 billion by 2033. The market is predicted at a CAGR of 8% during the forecast period.
Peptide Synthesis Market – Driving Factors
Increasing Medication Issues Decline Market Growth
Rising chemical-produced medications and regulatory issues are the factors that may restrain market growth. The European Medicines Agency and Food and Drug Administration are also at odds in regulating the approval of medications based on the peptide. The lack of consistent rules and difficulty in permitting therapeutic peptides limit market growth.
How do Peptide Synthesis Manufacturers Drive Market Opportunities?
Advanced medicine and limited side effects increase the demand for peptide synthesis and market opportunities during the forecast period. The growing investment and key healthcare manufacturers pushing the investment in personalized medicine are driving market expansion. Growing technology of automated injection of various chemicals, such as membrane enhanced and ligand synthesis, is increasing the adoption of peptide synthesis.
Growing healthcare infrastructure and improvements in medications are boosting market opportunities. Manufacturers are advancing customized medicine, and individualized therapy for patients is further increasing market opportunities. The development of proteomic analysis and methods of determining molecular profiles greatly contribute to expanding the market growth.
The adoption of proteomics to clarify pathomechanisms illness is propelling the market size. The European Union scientist announced the development of user-friendly electrochemical customized peptide synthesis in the ElectroMed project, a technology to detect the interaction between immune receptors and short peptides. This customized peptide synthesis is typically based on a microfluidic multiplexing system.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 8% |
| Market Valuation (2023) | US$ 520 million |
| Market Valuation (2033) | US$ 1.1 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights, the global peptide synthesis market is predicted at a healthy 8% CAGR during the forecast period. Historically, the market registered a CAGR of 11.5% between 2017 and 2022.
The market is estimated to reach US$ 1.1 billion during the forecast period. Historically, the market stood at US$ 460.0 million from 2017 to 2022.
| Segments | Product and Services |
|---|---|
| Top Category | Reagents |
| Historic CAGR | 11.4% |
| Forecast CAGR | 7.8% |
| Segments | End Use |
|---|---|
| Top Category | Pharmaceuticals & Biotechnology Companies |
| Historic CAGR | 11.1% |
| Forecast CAGR | 7.6% |
Based on the product and services segment, the reagents category holds a maximum CAGR of 7.8% during the forecast period. The adoption of reagents widely in laboratories, pharmaceutical manufacturing, and research & development activities is driving the market growth.
Apart from reagents, coupling agents are also widely used by various chemical laboratories to identify or research a particular substance. These growing demand factors are flourishing the market expansion. Historically, the reagents captured a CAGR of 11.4% between 2017 and 2022.
Based on technology, the segment is divided into solid-phase peptide synthesis, solution-phase peptide synthesis, and membrane-enhanced peptide synthesis technology. Pharmaceuticals & biotechnology sectors use different technology to develop a certain product type. Therefore, chemical synthesis is the commonly used process for peptide production in these industries.
This process has influenced the adoption of enzymatic technology. Though, the changing environment and manufacturing caps on industries slow down the growth of this segment. The process of chemical synthesis triggers pollution and environmental risks.
Based on end use, there are several industries like CDMOs & CROs, pharmaceuticals & biotechnology, academics & research institutions, and others. Pharmaceuticals and biotechnology are leading the segment by securing a CAGR of 7.6% during the forecast period. The adoption of peptide synthesis for the development of therapeutic in pharmaceuticals & biotechnology is bolstering the market growth.
The growing demand for drugs and vaccines with peptide synthesis is driving the pharmaceutical sector. For instance, AstraZeneca launched new advanced peptide therapy and next-generation medicine through research and development programs. FDA-approved Rybelsus tablets for diabetes type 2 patients. Historically, pharmaceuticals & biotechnology secured a CAGR of 11.1% between 2017 and 2020.
Principal Consultant
| Countries | United States |
|---|---|
| CAGR (2017 to 2022) | 13.5% |
| CAGR (2023 to 2023) | 7.8% |
| Valuation (2023 to 2033) | US$ 398.6 million |
| Countries | United Kingdom |
|---|---|
| CAGR (2017 to 2022) | 12.5% |
| CAGR (2023 to 2023) | 7.1% |
| Valuation (2023 to 2033) | US$ 47.3 million |
| Countries | China |
|---|---|
| CAGR (2017 to 2022) | 13.1% |
| CAGR (2023 to 2023) | 7.4% |
| Valuation (2023 to 2033) | US$ 80.7 million |
| Countries | Japan |
|---|---|
| CAGR (2017 to 2022) | 12% |
| CAGR (2023 to 2023) | 6.5% |
| Valuation (2023 to 2033) | US$ 66 million |
| Countries | South Korea |
|---|---|
| CAGR (2017 to 2022) | 11.1% |
| CAGR (2023 to 2023) | 6% |
| Valuation (2023 to 2033) | US$ 39.6 million |
The United States dominates the global market by securing a CAGR of 7.8% with a valuation of US$ 398.6 million during the forecast period. The rise in chronic patients adopting peptide-based vaccines and drugs propels the United States market. In 2022, according to the American Cancer Society, around 1.9 million new cancer cases grew in the United States. Cancer is a prior deadly disease after a heart attack in the United States.
Increasing rates of diabetes patients, inactive lifestyles, and obesity are fueling the United States peptide synthesis market. In addition, the development of modern drugs and increasing government investment are expanding the United States market. Historically, the United States secured a CAGR of 13.5% between 2017 and 2022.
The United Kingdom captured a CAGR of 7.1% with a valuation of US$ 47.3 million during the forecast period. Developing advanced chemical and organic peptides with a high investment in research and development activities is expanding the United States market. In addition, the growing risk of chronic diseases and the presence of the biochemical industry is surging the United States peptide synthesis market.
The rising urbanization, healthcare infrastructure, and manufacturing industry are expanding the market. Historically, the United Kingdom secured a CAGR of 12.5% between 2017 and 2020.
China is contributing a CAGR of 7.4% with a valuation of US$ 80.7 million during the forecast period. Increasing research and development investment and the biotech sector are flourishing in China's peptide synthesis market growth. In addition, rising demand for the minimal cost of raw materials and the adoption of advanced therapy is further increasing the China market expansion.
Lack of proper diet, a sedentary lifestyle, and low physical activities result in chronic diseases, increasing the demand for peptide synthesis. Moreover, the present prominent players and the development of new technologies in peptide synthesis are driving China market. Historically, China secured a CAGR of 13.1% between 2017 and 2020.
The multiple established companies and the presence of key players consolidate the market. In addition, due to the modernization of medical research and development projects and rising pharmaceutical manufacturing, the key competitors focus on providing effective products and services.
By adopting several marketing tactics and deep market research, the market players are increasing the sales of peptide synthesis products. Their marketing tactics are mergers, acquisitions, collaborations, and partnerships.
Recent Developments in the Market:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, Canada, Germany, United Kingdom., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa, South Africa, and Türkiye |
| Key Segments Covered | Product and Services, Technology, End Use, Region |
| Key Companies Profiled | GenScript Biotech Corporation; Bachem Holding AG; Thermo Fisher Scientific Inc; Merck KGaA; Kaneka Corporation |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market in 2023 is valued at US$ 520.0 million.
By 2033, the market will expand at a 8% CAGR.
By 2033, the market will reach US$ 1.1 billion.
From 2018 to 2022, the global market exhibited a 11.5% CAGR.
Merck KGaA, Kaneka Corporation
1. Executive Summary | Peptide Synthesis Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product and Service
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product and Service, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product and Service, 2023 to 2033
5.3.1. Reagents
5.3.2. Equipment
5.3.3. Services
5.4. Y-o-Y Growth Trend Analysis By Product and Service, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product and Service, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033
6.3.1. Solid-Phase Peptide Synthesis
6.3.2. Solution-Phase Peptide Synthesis
6.3.3. Hybrid & Recombinant Technology
6.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End Use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End Use , 2017 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use , 2023 to 2033
7.3.1. Pharmaceuticals & Biotechnology Companies
7.3.2. CDMOs & CROs
7.3.3. Academics & Research Institutes
7.4. Y-o-Y Growth Trend Analysis By End Use , 2017 to 2022
7.5. Absolute $ Opportunity Analysis By End Use , 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product and Service
9.2.3. By Technology
9.2.4. By End Use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product and Service
9.3.3. By Technology
9.3.4. By End Use
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product and Service
10.2.3. By Technology
10.2.4. By End Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product and Service
10.3.3. By Technology
10.3.4. By End Use
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product and Service
11.2.3. By Technology
11.2.4. By End Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product and Service
11.3.3. By Technology
11.3.4. By End Use
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Thailand
12.2.1.5. Singapore
12.2.1.6. Australia
12.2.1.7. Rest of Asia Pacific
12.2.2. By Product and Service
12.2.3. By Technology
12.2.4. By End Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product and Service
12.3.3. By Technology
12.3.4. By End Use
12.4. Key Takeaways
13. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of Middle East and Africa
13.2.2. By Product and Service
13.2.3. By Technology
13.2.4. By End Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product and Service
13.3.3. By Technology
13.3.4. By End Use
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Product and Service
14.1.2.2. By Technology
14.1.2.3. By End Use
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Product and Service
14.2.2.2. By Technology
14.2.2.3. By End Use
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Product and Service
14.3.2.2. By Technology
14.3.2.3. By End Use
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Product and Service
14.4.2.2. By Technology
14.4.2.3. By End Use
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Product and Service
14.5.2.2. By Technology
14.5.2.3. By End Use
14.6. United Kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Product and Service
14.6.2.2. By Technology
14.6.2.3. By End Use
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Product and Service
14.7.2.2. By Technology
14.7.2.3. By End Use
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Product and Service
14.8.2.2. By Technology
14.8.2.3. By End Use
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Product and Service
14.9.2.2. By Technology
14.9.2.3. By End Use
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Product and Service
14.10.2.2. By Technology
14.10.2.3. By End Use
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Product and Service
14.11.2.2. By Technology
14.11.2.3. By End Use
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Product and Service
14.12.2.2. By Technology
14.12.2.3. By End Use
14.13. Thailand
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Product and Service
14.13.2.2. By Technology
14.13.2.3. By End Use
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Product and Service
14.14.2.2. By Technology
14.14.2.3. By End Use
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Product and Service
14.15.2.2. By Technology
14.15.2.3. By End Use
14.16. GCC Countries
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Product and Service
14.16.2.2. By Technology
14.16.2.3. By End Use
14.17. South Africa
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By Product and Service
14.17.2.2. By Technology
14.17.2.3. By End Use
14.18. Israel
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By Product and Service
14.18.2.2. By Technology
14.18.2.3. By End Use
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product and Service
15.3.3. By Technology
15.3.4. By End Use
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. GenScript Biotech Corporation
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Bachem Holding AG
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Thermo Fisher Scientific Inc.
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Merck KGaA
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Kaneka Corporation
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Biotage AB
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Syngene International Limited
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Mesa Laboratories, Inc.
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Cem Corporation
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Proteogenix
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Peptide Synthesis Market
